Related Experiment Video
Updated: Jun 8, 2026
09:48
Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
Published on: August 23, 2024
Aptamer conjugated magnetic nanoparticles as nanosurgeons
Baiju G Nair1, Yutaka Nagaoka1,2, Hisao Morimoto1,2
1Graduate School of Interdisciplinary New Science, Toyo University, Kawagoe, Saitama 350-8585, Japan.
Nanotechnology
|October 16, 2010
Summary
Researchers developed a "nanosurgeon" using magnetic nanoparticles and an external magnetic field to selectively remove cancer cells. This innovative approach offers a precise method for cancer cell destruction, preventing proliferation and potential for future surgical applications.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Magnetic nanoparticles (MNPs) are promising for cancer therapy, including drug delivery, hyperthermia, and MRI.
- Selective removal of cancerous cells without collateral damage is a significant surgical challenge due to cancer's infiltrative nature.
Purpose of the Study:
- To develop a novel nanosurgeon system for precise, selective removal of target cancer cells.
- To utilize aptamer-conjugated MNPs controlled by a 3D rotational magnetic field for surgical applications.
Main Methods:
- A nanosurgeon system was engineered using aptamer-conjugated magnetic nanoparticles.
- An external three-dimensional rotational magnetic field controlled the movement and action of the MNPs.
- In vitro studies were conducted to assess the nanosurgeon's efficacy on target cells.
Main Results:
- The nanosurgeon successfully performed surgical actions on target cells in vitro.
- Lactate dehydrogenase (LDH) and intracellular calcium release assays confirmed cancer cell death.
- The system effectively nullified the proliferation potential of removed cancer cells.
Conclusions:
- The developed nanosurgeon is a viable tool for selective surgery and cell manipulation in cancer therapy.
- This technology has the potential to be upgraded for treating complex cancers in diverse tissues by incorporating specific targeting ligands.
